{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T08:24:41Z","timestamp":1777537481102,"version":"3.51.4"},"reference-count":42,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Psychiatric Research"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1016\/j.jpsychires.2012.08.017","type":"journal-article","created":{"date-parts":[[2012,8,30]],"date-time":"2012-08-30T01:52:37Z","timestamp":1346291557000},"page":"1511-1514","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Peripheral brain-derived neurotrophic factor changes along treatment with extended release quetiapine during acute mood episodes: An open-label trial in drug-free patients with bipolar disorder"],"prefix":"10.1016","volume":"46","author":[{"given":"Iria","family":"Grande","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fl\u00e1vio","family":"Kapczinski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Stertz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriela Delevatti","family":"Colpo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauricio","family":"Kunz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keila Mendes","family":"Cereser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcia","family":"Kauer-Sant'Anna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benicio","family":"Frey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduard","family":"Vieta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro V.S.","family":"Magalhaes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpsychires.2012.08.017_bib1","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.psychres.2006.03.025","article-title":"DNA damage in bipolar disorder","volume":"153","author":"Andreazza","year":"2007","journal-title":"Psychiatry Research"},{"key":"10.1016\/j.jpsychires.2012.08.017_bib2","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jad.2008.04.013","article-title":"Oxidative stress markers in bipolar disorder: a meta-analysis","volume":"111","author":"Andreazza","year":"2008","journal-title":"Journal of Affective Disorders"},{"key":"10.1016\/j.jpsychires.2012.08.017_bib3","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1124\/pr.111.005108","article-title":"Brain-derived neurotrophic factor and neuropsychiatric disorders","volume":"64","author":"Autry","year":"2012","journal-title":"Pharmacological Reviews"},{"key":"10.1016\/j.jpsychires.2012.08.017_bib4","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1399-5618.2011.00889.x","article-title":"Does stage of illness impact treatment response in bipolar disorder? Empirical treatment data and their implication for the staging model and early intervention","volume":"13","author":"Berk","year":"2011","journal-title":"Bipolar Disorders"},{"key":"10.1016\/j.jpsychires.2012.08.017_bib5","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.neubiorev.2010.10.001","article-title":"Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors","volume":"35","author":"Berk","year":"2011","journal-title":"Neuroscience & Biobehavioral Reviews"},{"key":"10.1016\/j.jpsychires.2012.08.017_bib6","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/YIC.0b013e32834e4c56","article-title":"Quetiapine for bipolar depression: a systematic review and meta-analysis","volume":"27","author":"Chiesa","year":"2012","journal-title":"International Clinical Psychopharmacology"},{"key":"10.1016\/j.jpsychires.2012.08.017_bib7","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1399-5618.2006.00315.x","article-title":"Symptomatic and functional outcome 12 months after a first episode of psychotic mania: barriers to recovery in a catchment area sample","volume":"8","author":"Conus","year":"2006","journal-title":"Bipolar Disorders"},{"issue":"Suppl. 1","key":"10.1016\/j.jpsychires.2012.08.017_bib8","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1038\/sj.mp.4001016","article-title":"Synaptic plasticity and mood disorders","volume":"7","author":"Duman","year":"2002","journal-title":"Molecular Psychiatry"},{"key":"10.1016\/j.jpsychires.2012.08.017_bib9","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.jpsychires.2011.03.002","article-title":"Brain-derived neurotrophic factor as a state-marker of mood episodes in bipolar disorders: a systematic review and meta-regression analysis","volume":"45","author":"Fernandes","year":"2011","journal-title":"Journal of Psychiatric Research"},{"key":"10.1016\/j.jpsychires.2012.08.017_bib10","series-title":"Structured clinical interview for DSM-IV axis I disorders, research version, patient edition (SCID-I\/P)","author":"First","year":"2002"},{"key":"10.1016\/j.jpsychires.2012.08.017_bib11","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1097\/00001756-200409150-00022","article-title":"Quetiapine regulates FGF-2 and BDNF expression in the hippocampus of animals treated with MK-801","volume":"15","author":"Fumagalli","year":"2004","journal-title":"Neuroreport"},{"key":"10.1016\/j.jpsychires.2012.08.017_bib12","doi-asserted-by":"crossref","first-page":"243","DOI":"10.4306\/pi.2010.7.4.243","article-title":"The role of BDNF as a mediator of neuroplasticity in bipolar disorder","volume":"7","author":"Grande","year":"2010","journal-title":"Psychiatry Investigation"},{"key":"10.1016\/j.jpsychires.2012.08.017_bib13","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.physbeh.2011.10.029","article-title":"Mediators of allostasis and systemic toxicity in bipolar disorder","volume":"106","author":"Grande","year":"2012","journal-title":"Physiology & Behavior"},{"key":"10.1016\/j.jpsychires.2012.08.017_bib14","series-title":"ECDEU assessment manual for psychopharmacology","author":"Guy","year":"1976"},{"key":"10.1016\/j.jpsychires.2012.08.017_bib15","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jpsychires.2010.05.015","article-title":"Peripheral biomarkers and illness activity in bipolar disorder","volume":"45","author":"Kapczinski","year":"2011","journal-title":"Journal of Psychiatric Research"},{"key":"10.1016\/j.jpsychires.2012.08.017_bib16","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0304-3940(02)00529-3","article-title":"Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and platelets","volume":"328","author":"Karege","year":"2002","journal-title":"Neuroscience Letters"},{"key":"10.1016\/j.jpsychires.2012.08.017_bib17","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1017\/S1461145708009310","article-title":"Brain-derived neurotrophic factor and inflammatory markers in patients with early- vs. late-stage bipolar disorder","volume":"12","author":"Kauer-Sant'Anna","year":"2009","journal-title":"International Journal of Neuropsychopharmacology"},{"key":"10.1016\/j.jpsychires.2012.08.017_bib18","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.biopsych.2007.01.002","article-title":"Correlation between serum brain-derived neurotrophic factor level and an in\u00a0vivo marker of cortical integrity","volume":"62","author":"Lang","year":"2007","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.jpsychires.2012.08.017_bib19","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/j.1399-5618.2010.00835.x","article-title":"Effects of recurrence on the cognitive performance of patients with bipolar I disorder: implications for relapse prevention and treatment adherence","volume":"12","author":"L\u00f3pez-Jaramillo","year":"2010","journal-title":"Bipolar Disorders"},{"key":"10.1016\/j.jpsychires.2012.08.017_bib20","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.brainres.2005.09.043","article-title":"Quetiapine reverses the suppression of hippocampal neurogenesis caused by repeated restraint stress","volume":"1063","author":"Luo","year":"2005","journal-title":"Brain Research"},{"key":"10.1016\/j.jpsychires.2012.08.017_bib21","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1600-0447.2011.01794.x","article-title":"Illness burden and medical comorbidity in the systematic treatment enhancement program for bipolar disorder","volume":"125","author":"Magalh\u00e3es","year":"2012","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1016\/j.jpsychires.2012.08.017_bib22","doi-asserted-by":"crossref","DOI":"10.1038\/nrn3229","article-title":"Impaired mitochondrial function in psychiatric disorders","author":"Manji","year":"2012","journal-title":"Nature Reviews. Neuroscience"},{"key":"10.1016\/j.jpsychires.2012.08.017_bib23","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1517\/14656566.8.9.1211","article-title":"A\u00a0preclinical and clinical rationale for quetiapine in mood syndromes","volume":"8","author":"McIntyre","year":"2007","journal-title":"Expert Opinion on Pharmacotherapy"},{"key":"10.1016\/j.jpsychires.2012.08.017_bib24","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.schres.2006.05.028","article-title":"Decreased levels of plasma BDNF in first-episode schizophrenia and bipolar disorder patients","volume":"86","author":"Palomino","year":"2006","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.jpsychires.2012.08.017_bib25","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.neulet.2006.03.028","article-title":"Effects of quetiapine on the brain-derived neurotrophic factor expression in the hippocampus and neocortex of rats","volume":"402","author":"Park","year":"2006","journal-title":"Neuroscience Letters"},{"key":"10.1016\/j.jpsychires.2012.08.017_bib26","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.jpsychires.2006.09.009","article-title":"Role of BDNF in bipolar and unipolar disorder: clinical and theoretical implications","volume":"41","author":"Post","year":"2007","journal-title":"Journal of Psychiatric Research"},{"key":"10.1016\/j.jpsychires.2012.08.017_bib27","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1600-0447.2011.01830.x","article-title":"One-year psychosocial functioning in patients in the early vs. late stage of bipolar disorder","volume":"125","author":"Rosa","year":"2012","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1016\/j.jpsychires.2012.08.017_bib28","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1038\/npp.2010.114","article-title":"Peripheral BDNF produces antidepressant-like effects in cellular and behavioral models","volume":"35","author":"Schmidt","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jpsychires.2012.08.017_bib29","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/j.1755-5949.2011.00262.x","article-title":"Neurocognitive impairment across the bipolar spectrum","volume":"18","author":"Sole","year":"2012","journal-title":"CNS Neuroscience & Therapeutics"},{"key":"10.1016\/j.jpsychires.2012.08.017_bib30","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1017\/S1461145709991246","article-title":"Level of response and safety of pharmacological monotherapy in the treatment of acute bipolar I disorder phases: a systematic review and meta-analysis","volume":"13","author":"Tamayo","year":"2010","journal-title":"International Journal of Neuropsychopharmacology"},{"key":"10.1016\/j.jpsychires.2012.08.017_bib31","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1399-5618.2009.00726.x","article-title":"The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disorders","volume":"11","author":"Tohen","year":"2009","journal-title":"Bipolar Disorders"},{"key":"10.1016\/j.jpsychires.2012.08.017_bib32","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.comppsych.2010.12.009","article-title":"Effects of atypical antipsychotics on neurocognition in euthymic bipolar patients","volume":"52","author":"Torrent","year":"2011","journal-title":"Comprehensive Psychiatry"},{"key":"10.1016\/j.jpsychires.2012.08.017_bib33","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.neulet.2009.01.028","article-title":"Brain-derived neurotrophic factor serum levels before and after treatment for acute mania","volume":"452","author":"Tramontina","year":"2009","journal-title":"Neuroscience Letters"},{"key":"10.1016\/j.jpsychires.2012.08.017_bib34","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/hup.689","article-title":"Mood stabilization in the treatment of bipolar disorder: focus on quetiapine","volume":"20","author":"Vieta","year":"2005","journal-title":"Human Psychopharmacology: Clinical & Experimental"},{"key":"10.1016\/j.jpsychires.2012.08.017_bib35","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/JCP.0b013e3181f15849","article-title":"Treatment options for bipolar depression: a systematic review of randomized, controlled trials","volume":"30","author":"Vieta","year":"2010","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1016\/j.jpsychires.2012.08.017_bib36","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1017\/S0954579498001667","article-title":"The design and analysis of longitudinal studies of development and psychopathology in context: statistical models and methodological recommendations","volume":"10","author":"Willett","year":"1998","journal-title":"Development and Psychopathology"},{"key":"10.1016\/j.jpsychires.2012.08.017_bib37","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1001\/archpsyc.1988.01800320058007","article-title":"A\u00a0structured interview guide for the Hamilton Depression Rating Scale","volume":"45","author":"Williams","year":"1988","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.jpsychires.2012.08.017_bib38","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/hipo.20184","article-title":"Synergetic effects of quetiapine and venlafaxine in preventing the chronic restraint stress-induced decrease in cell proliferation and BDNF expression in rat hippocampus","volume":"16","author":"Xu","year":"2006","journal-title":"Hippocampus"},{"key":"10.1016\/j.jpsychires.2012.08.017_bib39","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1399-5618.2009.00672.x","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009","volume":"11","author":"Yatham","year":"2009","journal-title":"Bipolar Disorders"},{"key":"10.1016\/j.jpsychires.2012.08.017_bib40","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.pnpbp.2009.12.003","article-title":"Adding a low dose atypical antipsychotic drug to an antidepressant induced a rapid increase of plasma brain-derived neurotrophic factor levels in patients with treatment-resistant depression","volume":"34","author":"Yoshimura","year":"2010","journal-title":"Progress in Neuro-Psychopharmacology and Biological Psychiatry"},{"key":"10.1016\/j.jpsychires.2012.08.017_bib41","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.pnpbp.2007.03.001","article-title":"Effects of paroxetine or milnacipran on serum brain-derived neurotrophic factor in depressed patients","volume":"31","author":"Yoshimura","year":"2007","journal-title":"Progress in Neuro-Psychopharmacology and Biological Psychiatry"},{"key":"10.1016\/j.jpsychires.2012.08.017_bib42","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1192\/bjp.133.5.429","article-title":"A\u00a0rating scale for mania: reliability, validity and sensitivity","volume":"133","author":"Young","year":"1978","journal-title":"The British Journal of Psychiatry"}],"container-title":["Journal of Psychiatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395612002506?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395612002506?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T11:07:43Z","timestamp":1758366463000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022395612002506"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":42,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S0022395612002506"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychires.2012.08.017","relation":{},"ISSN":["0022-3956"],"issn-type":[{"value":"0022-3956","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Peripheral brain-derived neurotrophic factor changes along treatment with extended release quetiapine during acute mood episodes: An open-label trial in drug-free patients with bipolar disorder","name":"articletitle","label":"Article Title"},{"value":"Journal of Psychiatric Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpsychires.2012.08.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}